Acura Pharmaceuticals, Inc

Ownership Transactions Reported by 10 Insiders

Symbol
ACUR on OTC
Industry
Pharmaceutical Preparations
Location
616 N. North Court, Suite 120, Palatine, IL

There are no Buy or Sell transactions made by insiders since 9/19/2023

Acura Pharmaceuticals, Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
John Schutte 10%+ Owner $8.3M Jun 9, 2021
Abuse Deterrent Pharma, LLC 10%+ Owner $6.88M Jun 9, 2021
Immanuel Thangaraj Director $393K Jan 2, 2024
Bruce Wesson Director, Director Emeritus $133K Jan 2, 2024
Robert B. Jones President & CEO $103K Nov 20, 2023
William Skelly Director $100K Jan 2, 2024
George Ross Director $87.3K Jan 2, 2024
Peter A. Clemens Senior VP & CFO $87.3K Nov 20, 2023
Albert W. Brzeczko VP, Pharmaceutical Sciences - APT $77.8K Nov 20, 2023
Robert A. Seiser VP, Treasurer & Controller $70.1K Nov 20, 2023

Recent Insider Transactions by Companies or Individuals for Acura Pharmaceuticals, Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.